Xiaohao Ruan

ORCID: 0000-0001-8373-5237
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Genetic Associations and Epidemiology
  • Urologic and reproductive health conditions
  • Multiple and Secondary Primary Cancers
  • Cancer, Lipids, and Metabolism
  • Global Cancer Incidence and Screening
  • BRCA gene mutations in cancer
  • Genetic factors in colorectal cancer
  • Renal cell carcinoma treatment
  • Epigenetics and DNA Methylation
  • Nutrition, Genetics, and Disease
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer-related molecular mechanisms research
  • Renal and related cancers
  • Pediatric Urology and Nephrology Studies
  • Radiopharmaceutical Chemistry and Applications
  • Synthetic Aperture Radar (SAR) Applications and Techniques
  • Ferroptosis and cancer prognosis
  • Healthcare Policy and Management
  • Extracellular vesicles in disease
  • Urinary Bladder and Prostate Research
  • Advanced Image Fusion Techniques
  • Cancer-related gene regulation
  • Telomeres, Telomerase, and Senescence

Ruijin Hospital
2021-2024

Shanghai Jiao Tong University
2021-2024

University of Hong Kong
2022-2023

Chinese University of Hong Kong
2022

China University of Geosciences (Beijing)
2021

Prostate cancer (PCa) is one of the most lethal causes cancer-related death in male. It characterized by chromosomal instability and disturbed signaling transduction. E3 ubiquitin ligases are well-recognized as mediators leading to genomic alterations malignant phenotypes. There a lack systematic study on novel oncodrivers with clinical significance PCa. In this we used clustered regularly interspaced short palindromic repeats (CRISPR) system screen 656 or tumor repressors PCa cells. We...

10.1016/j.drup.2022.100912 article EN cc-by-nc-nd Drug Resistance Updates 2023-01-03

Abstract Aberrant epigenetic reprogramming represents a hallmark of renal cell carcinoma (RCC) tumorigenesis and progression. Whether there existed other vulnerabilities that could serve as therapeutic targets remained unclear promising. Here, we combined the clustered regularly interspaced short palindromic repeats functional screening results multiple RCC datasets to identify JMJD6 potent target in RCC. expression correlated with poor survival outcomes patients promoted progression vitro...

10.1002/ctm2.328 article EN cc-by Clinical and Translational Medicine 2021-02-01

Background The status of prostate-specific antigen (PSA) screening is unclear in China. Evidence regarding the optimal frequency and interval serial for prostate cancer (PCa) disputable. Objective This study aimed to depict PSA explore PCa Methods A 13-year prospective cohort was conducted using Chinese Electronic Health Records Research Yinzhou study’s data set. total 420,941 male participants aged ≥45 years were included between January 2009 June 2022. Diagnosis PCa, cancer-specific death,...

10.2196/47161 article EN cc-by JMIR Public Health and Surveillance 2024-01-18

To accurately describe dynamic vegetation changes, high temporal and spectral resolution data are urgently required. Optical images contain rich information but limited by poor weather conditions cloud contamination. Conversely, synthetic-aperture radar (SAR) is effective under all contains insufficient to recognize certain changes. Conditional adversarial networks (cGANs) can be adopted transform SAR (Sentinel-1) into optical (Landsat8), which exploits the advantages of both images. As...

10.3390/rs13010128 article EN cc-by Remote Sensing 2021-01-01

Genome-wide association studies have identified 270 loci conferring risk for prostate cancer (PCa), yet the underlying biology and clinical impact remain to be investigated. Here we observe an enrichment of transcription factor genes including HNF1B within PCa risk-associated regions. While focused on 17q12/HNF1B locus, find a strong eQTL multiple potential causal variants involved in regulation expression PCa. An unbiased genome-wide co-expression analysis reveals PCa-specific somatic...

10.1038/s41467-022-34994-z article EN cc-by Nature Communications 2022-11-28

The risk of second primary cancers (SPC) is increasing after the first (FPC) are diagnosed and treated. underlying causal relationship remains unclear. We conducted a pan-cancer association (26 cancers) study in Surveillance, Epidemiology, End Results (SEER) database (non-Hispanic whites). standardized incidence ratio (SIR) was estimated as SPCs cancer survivors based on general population. Furthermore, effect evaluated by two-sample Mendelian Randomization (MR, 13 FPCs) UK Biobank (UKB,...

10.7554/elife.86379 article EN cc-by eLife 2023-11-02

Abstract MicroRNAs (miRNAs) are involved in the regulation of gene expression via incomplete base pairing to sequence motifs at three prime untranslated regions (3′‐UTRs) mRNAs and play critical roles etiology cancers. Single nucleotide polymorphisms (SNPs) 3′‐UTR miRNA‐binding may influence miRNA affinity. However, this biological mechanism prostate cancer (PCa) remains unclear. Here, a three‐stage genome‐wide association study SNPs ( n =33 117) is performed 5515 Chinese men. Three...

10.1002/advs.202201420 article EN Advanced Science 2022-06-17

Abstract Background Legislation of cannabis use has been approved in many European and North American countries. Its impact on urological cancers is unclear. This study was conducted to explore the association between risk cancers. Methods We identified 151,945 individuals with information UK Biobank from 2006 2010. Crude age‐standardized incidence ratios different were evaluated entire cohort subgroups. Cox regression performed for survival analysis. Results Previous a significant...

10.1002/cam4.5132 article EN cc-by Cancer Medicine 2022-08-17

Anticipating the postoperative pathological stage and potential for adverse features of prostate cancer (PCa) patients before radical prostatectomy (RP) is crucial guiding perioperative treatment.

10.1002/cam4.70085 article EN cc-by Cancer Medicine 2024-08-01

Currently, prostate cancer (PCa) prebiopsy medical image diagnosis mainly relies on mpMRI and PI-RADS scores. However, has its limitations, such as inter- intra-radiologist variability the potential for imperceptible features. The primary objective of this study is to evaluate effectiveness a machine learning model based radiomics analysis MRI T2-weighted (T2w) images predicting PCa in cases.

10.3390/cancers16172944 article EN Cancers 2024-08-23

Polygenic risk score (PRS) has shown promise in predicting prostate cancer (PCa) risk. However, the application of PRS non-European ancestry was poorly studied.We constructed using 68, 86, or 128 PCa-associated single-nucleotide polymorphisms (SNPs) identified through a large-scale Genome-wide association study (GWAS) European population. A calibration approach performed to adjust exact value for each ancestry. The conducted East Asian (ChinaPCa Consortium, n = 2379), (UK Biobank, 209,172),...

10.1002/pros.24431 article EN The Prostate 2022-08-22

This study aimed to evaluate the clinical utility of 18F-PSMA-1007 positron emission tomography (PSMA PET)/magnetic resonance imaging (MRI) in patients with suspected or defined prostate cancer.In pilot study, we retrospectively investigated 62 who underwent PSMA-PET/MRI for PCa between June 2019 and 2020. Patients were grouped into three subgroups: (1) without histological evidence, (2) primary PCa, (3) biochemical recurrent cancer (BRPCa). Two nuclear physicians independently interpreted...

10.3389/fonc.2020.612701 article EN cc-by Frontiers in Oncology 2021-02-11

Urine culture is time consuming, which may take days to get the results and impede further timely treatment. Our objective evaluate whether fast urinalysis bacterial discrimination system called Sysmex UF-5000 predict urinary tract infections (UTIs) (within minutes) compared with clinical routine test in suspected UTI patients. In addition, we aimed explore accuracy of microbiologic information by UF-5000.Consecutive patients who were admitted from emergency department at Queen Mary Hospital...

10.3389/fcimb.2022.936854 article EN cc-by Frontiers in Cellular and Infection Microbiology 2022-09-27

To date, the combined effect of polygenic risk score (PRS) and prostate health index (phi) on PCa diagnosis in men undergoing biopsy has never been investigated. A total 3166 patients who underwent initial three tertiary medical centers from August 2013 to March 2019 were included. PRS was calculated basis genotype 102 reported East-Asian-specific variants. It then evaluated univariable or multivariable logistic regression models that internally validated using repeated 10-fold...

10.3390/jcm12041343 article EN Journal of Clinical Medicine 2023-02-08

Early evidence is disputable for the effects of modifiable lifestyle behaviors on prostate cancer (PCa) risk. No research has yet appraised such causality in different ancestries using a Mendelian randomization (MR) approach.A two-sample univariable and multivariable MR analysis was performed. Genetic instruments associated with were selected based genome-wide association studies. Summary-level data PCa obtained from PRACTICAL GAME-ON/ELLIPSE consortia Europeans (79,148 cases 61,106...

10.3390/biology12050673 article EN cc-by Biology 2023-04-29

Abstract Background Prostate health index ( phi ), a derivative of [−2]proPSA (p2PSA), has shown better accuracy than prostate‐specific antigen (PSA) in prostate cancer (PCa) detection. The present study was to investigate whether previously identified PSA‐associated single nucleotide polymorphisms (SNPs) influence p2PSA or levels and lead potential clinical utility. Methods We conducted an observational prospective with 2268 consecutive patients who underwent biopsy three tertiary medical...

10.1002/pros.24192 article EN cc-by-nc-nd The Prostate 2021-07-12

Abstract Backgrounds: Urinary stone disease (USD, or urolithiasis) is common and poses a significant healthcare burden health economic in working-age population. We aim to provide epidemiological insights into the prevalence, incidence, trends, risk factors of USD among Chinese Methods: A prospective cohort study 966,481 participants from CHinese Electronic Records Research during 2009-2022 Yinzhou, China (CHERRY). Temporal trends were estimated by annual percentage changes (APC) using...

10.21203/rs.3.rs-3932510/v1 preprint EN cc-by Research Square (Research Square) 2024-02-19

This study aimed to figure out whether the combination of prostate health index (PHI) and prostate-specific membrane antigen (PSMA)-PET/MR could improve diagnostic accuracy for cancer (PCa) than that each individual method used alone.

10.1016/j.ajur.2023.10.003 article EN cc-by-nc-nd Asian journal of urology 2024-02-29

Abstract Systematic prostate biopsy has limitations, such as overdiagnosis of clinically insignificant cancer and underdiagnosis significant cancer. Magnetic resonance imaging (MRI)-guided biopsy, a promising alternative, might improve diagnostic accuracy. To compare the detection rates systematic combined (systematic plus MRI-targeted biopsy) in Asian men, we conducted retrospective cohort study men who underwent either or at two medical centers (Queen Mary Hospital Tung Wah Hospital, Hong...

10.4103/aja202412 article EN cc-by-nc-sa Asian Journal of Andrology 2024-05-14

Active surveillance/watchful waiting (AS/WW) is feasible and effective for favorable-risk prostate cancer (PCa). Understanding socioeconomic determinants of AS/WW may help determine the target population social support improve cancer-related survival.The Surveillance, Epidemiology, End Results Prostate with Watchful Waiting Database 18 Registries identified 229,428 adult men diagnosed primary localized PCa (clinical T1-T2c, N0M0) during a median follow-up 45 months between 2010 2016....

10.1002/cam4.5650 article EN cc-by Cancer Medicine 2023-02-02

Telomerase reverse transcriptase (TERT) has been consistently associated with prostate cancer (PCa) risk. However, few studies have explored the association between TERT variants and PCa aggressiveness.Individual genetic data were obtained from UK Biobank a Chinese cohort (Chinese Consortium for Prostate Cancer Genetics).A total of 209,694 Europeans (14,550 cases/195,144 controls) 8873 (4438 cases/4435 involved. Nineteen susceptibility loci five novel ones (rs144704378, rs35311994,...

10.3390/cancers15092650 article EN Cancers 2023-05-08

The genetic risk of aggressive prostate cancer (PCa) is hard to be assessed due the lack aggressiveness-related single-nucleotide polymorphisms (SNPs). Prostate volume (PV) a potential well-established factor for PCa, we hypothesize that polygenic score (PRS) based on benign hyperplasia (BPH) or PV-related SNPs may also predict PCa death.We evaluated PRS using 21 BPH/PV-associated SNPs, two established risk-related and 10 guideline-recommended hereditary genes in population-based UK Biobank...

10.1186/s12967-023-04316-y article EN cc-by Journal of Translational Medicine 2023-07-06

Abstract The aim of liquid biopsies is to obtain tumor information via the molecular interrogation samples, including blood and urine. As a minimally invasive procedure, have attracted attention. A series studies reported associations biomarkers such as circulating DNA, cell-free DNA extracellular vesicles with urological cancers, especially prostate cancer (PCa), demonstrated promising potential biopsies. In this review, we summarize recent clinical translational in PCa other bladder renal...

10.1017/pcm.2023.19 article EN cc-by-nc-nd Cambridge Prisms Precision Medicine 2023-01-01
Coming Soon ...